指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

沙特重症监护学会体外生命支持分会关于成人急性呼吸窘迫综合征应用静脉-静脉体外膜氧合的指南及2019冠状病毒病时代的特殊考虑

The Saudi Critical Care Society extracorporeal life support chapter guidance on utilization of veno-venous extracorporeal membrane oxygenation in adults with acute respiratory distress syndrome and special considerations in the era of coronavirus disease 2019.
指南 / 共识 · Saudi Med J · 2021-01-01
一句话结论沙特重症监护学会体外生命支持分会基于现有证据制定指南,为重型ARDS(尤其COVID-19)患者提供以安全为重点的ECMO救治指导。

该指南由沙特重症监护学会(SCCS)下属体外生命支持(ECLS)分会召集ECMO专家工作组制定,旨在基于现有证据为重型急性呼吸窘迫综合征(ARDS)患者,尤其是COVID-19相关ARDS患者,提供以安全为重点的ECMO使用指导。文中回顾了ECMO自2009年以来作为重型ARDS(主要由病毒病因引起)挽救性治疗的应用背景,以及COVID-19大流行的发展:截至2021年3月底全球COVID-19病例超过1.26亿例,沙特阿拉伯首例确诊病例报告于2020年3月2日,截至2021年3月底沙特阿拉伯累计确诊病例略高于36万例。该分会基于既往中东呼吸综合征冠状病毒大流行经验,预见SARS-CoV-2患者对ECMO治疗的需求,制定本指南以指导将ECMO作为重型ARDS患者的最后手段使用。

要点

  • ECMO被视为提供循环与通气支持的辅助治疗,可视为通向器官恢复的桥梁。
  • 自2009年起,ECMO已被用作重型成人ARDS患者的挽救性治疗,主要病因为病毒感染。
  • 该指南由沙特重症监护学会体外生命支持分会召集ECMO专家工作组制定,基于现有证据。
  • 指南聚焦于将ECMO作为重型ARDS患者,尤其是COVID-19患者的最后手段使用,并以安全为重点。
  • 截至2021年3月底,全球COVID-19病例超过1.26亿例;沙特阿拉伯首例确诊病例报告于2020年3月2日,累计确诊病例略高于36万例。

适用人群与场景

  • 成人重型急性呼吸窘迫综合征(ARDS)患者,尤其是COVID-19相关ARDS患者。
  • ECMO作为重型ARDS患者的最后手段(last resort)使用。

研究设计与关键结果

  • 制定机构:沙特重症监护学会(SCCS)下属体外生命支持(ECLS)分会召集的ECMO专家工作组。
  • 制定方法:基于现有证据制定指导文件,旨在为重型ARDS(尤其SARS-CoV-2)患者提供以安全为重点的ECMO服务简单指导。

证据类型、等级与局限

  • 证据类型:指南(guideline)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该指南可指导急诊/ICU医生将ECMO作为重型ARDS患者(尤其是COVID-19相关ARDS)的最后手段使用,并以安全为重点提供ECMO服务。

指南或共识出处

  • 沙特重症监护学会体外生命支持分会关于成人急性呼吸窘迫综合征应用静脉-静脉体外膜氧合的指南及2019冠状病毒病时代的特殊考虑(Saudi Med J)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Extracorporeal membrane oxygenation (ECMO) is considered as a supportive treatment that provides circulatory and ventilatory support and can be thought off as a bridge to organ recovery. Since 2009, it has been applied as a rescue treatment for patients with severe adult respiratory distress syndrome (ARDS) mainly due to viral causes. In December 2019, several patients presented with a constellation of symptoms of viral pneumonia in China. A new strain of the corona virus family, called COVID-19, has been discovered to be the cause of this severe mysterious illness that was named severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). This new virus continued to spread across the globe leading to the World Health Organization announcing it as a pandemic in the early 2020. By the end of March 2021, the number of COVID-19 cases worldwide exceeded 126 million cases. In Saudi Arabia, the first confirmed case of COVID-19 was reported in the 2nd March 2020. By the end of March 2021, the total number of confirmed COVID-19 cases in Saudi Arabia is just above 360,000. In anticipation of the need of ECMO for the treatment of patients with SARS‑CoV‑2 based on the previous Middle East respiratory syndrome coronavirus pandemic experience, the Saudi Extra-Corporeal Life Support (ECLS) chapter that is under the umbrella of the Saudi Critical Care Society (SCCS) convened a working group of ECMO experts. The mission of this group was to formulate a guidance for the use of ECMO as a last resort for patients with severe ARDS, especially with COVID-19 based on available evidence. The ECLS-SCCS chapter wanted to generate a document that can be used to simple guide, with a focus on safety, to provide ECMO service for patients with severe ARDS with a special focus on SARS‑CoV‑2.

来源:Saudi Med J,查看原文。版权归原作者所有。

参考来源

  1. Mufti HN, Rabie AA, Elhazmi AM, et al. The Saudi Critical Care Society extracorporeal life support chapter guidance on utilization of veno-venous extracorporeal membrane oxygenation in adults with acute respiratory distress syndrome and special considerations in the era of coronavirus disease 2019. Saudi Med J. 2021. PMID: 34078721. doi:10.15537/smj.2021.42.6.20200520

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。